查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1376011

miRNA 定序和分析市场规模、份额、趋势分析报告：按产品/服务、技术、工作流程、应用、最终用途、地区和细分市场进行预测，2023-2030 年

miRNA Sequencing And Assay Market Size, Share & Trends Analysis Report By Product & Service (Library Preparation Kits), By Technology, By Workflow, By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

miRNA 定序和检测市场成长和趋势：

Grand View Research, Inc.的最新报告显示，到2030年，全球miRNA定序和检测市场规模预计将达到8.235亿美元，2023年至2030年的年复合成长率为13.3%。

例如，各种研究表明，miRNA可以有效地用作癌症（子宫颈癌、卵巢癌和乳腺癌）、败血症、心血管疾病和神经系统疾病的预后和诊断的生物标记。因此，miRNA序列分析广泛应用于临床疾病的基因调控分析。例如，2022 年 3 月发表在 Frontiers 上的一篇论文指出，基于血液的 miRNA 生物标记可用于与基于大脑的 miRNA 表达相关。

COVID-19 大流行增强了 miRNA 的使用来识别冠状病毒的存在。 miRNA 生物标记可用于指示和诊断 COVID-19 的严重程度。 miRNA 在免疫反应、病毒增殖、受感染细胞的复製和心血管功能障碍中发挥重要作用。此外，从 COVID-19 患者身上采集的血浆富含抗体和抗病毒 miRNA。该药物正用于治疗感染 COVID-19 的患者。因此，越来越多的研究不仅关注病毒的 miRNA 定序，也关注患者的 miRNA 定序。

PerkinElmer Inc.、Illumina, Inc. 和 Qiagen 等知名公司为多种临床应用提供创新的定序产品。此外，这些公司也与研究机构达成了多项策略性倡议，以扩大定序在研究中的应用。例如，韩国生物製药公司 BIORCHESTRA 于 2022 年 1 月与 SK Biopharmaceuticals 签订合作协议，以加速针对 miRNA 的新型治疗化合物的研发。

市场上的主要参与者都参与开发具有高特异性和可重复性的新工具、设备和套件，这正在推动市场成长。例如，2019 年 10 月，TriLink BioTechnologies 宣布为其 CleanTag 试剂盒推出两套引子。 Thermo Fisher Scientific 的定序平台可以使用这些新的 Ion Torrent Convert 条码引子组来製备小 RNA 文库。此类产品的推出预计将促进市场成长。

miRNA 定序和检测市场报告亮点：

  • 该产品细分市场占据主导地位，2022 年收益占有率最大，约 80%。这是因为有几家主要企业为特定应用提供各种消耗品、套件和设备。
  • 从技术来看，合成定序领域占据市场主导地位，2022 年收益占有率最大，超过 32%。这是由于快速的周转时间、高灵敏度和高吞吐量。此外，它在检测肿瘤组织突变方面发挥重要作用，有助于开发个体化治疗。
  • 按工作流程来看，定序细分市场在 2022 年以超过 50% 的最大收益占有率占据市场主导地位，并且预计在预测期内将以 14.1% 的年复合成长率增长最快，因为它是工作流程中最关键的步骤。它已成为生物学研究和多种疾病诊断的重要研究工具。
  • 从应用来看，肿瘤领域占市场主导地位，2022年收益占有率最大，超过35%。一些正在进行的癌症研究使用 miRNA 作为生物标记来研究癌症预后和诊断以开发新的治疗方法，这些研究正在促进这一领域的成长。
  • 按最终用途划分，研究和学术机构产业占据市场主导地位，2022 年收益占有率最大，超过 50%。这一增长归因于学术机构使用 miRNA 定序技术进行的研发研究的增加。
  • 预计亚太地区在预测期内将以 15.4% 的年复合成长率增长最快。这是由于医疗保健基础设施的成长、目标人口的增加以及大量未满足的需求。

目录

第1章调查方法和范围

第2章执行摘要

第3章miRNA 定序和分析市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 普及和成长前景图
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • miRNA 定序和检测市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章miRNA 定序与检测：产品与服务评估及趋势分析

  • miRNA 定序与检测市场：重点
  • miRNA 定序与分析市场：2022 年和 2030 年趋势与市场占有率分析
  • 产品
    • 2018年至2030年产品市场预测
    • 文库製备试剂盒
    • 定序消耗品
    • 装置
  • 服务
    • 2018年至2030年服务市场估计与预测

第5章miRNA定序与检测：技术评估与趋势分析

  • miRNA 定序与检测市场：重点
  • miRNA 定序与分析市场：2022 年和 2030 年趋势与市场占有率分析
  • 合成定序
  • 透过寡核苷酸连接和检测进行定序 (SOLiD)
  • 奈米孔定序
  • 桑格序列测定
  • 单分子即时 (SMRT) 定序

第6章miRNA 定序与检测：工作流程估计与趋势分析

  • miRNA 定序与检测市场：重点
  • miRNA 定序与分析市场：2022 年和 2030 年趋势与市场占有率分析
  • 准备图书馆
    • 2018年至2030年文库製备市场估计与预测
  • 定序
    • 2018年至2030年的定序市场估计与预测
  • 资料分析与存储
    • 2018年至2030年资料分析及储存市场预测

第7章miRNA 定序与检测：应用评估与趋势分析

  • miRNA 定序与检测市场：重点
  • miRNA 定序与分析市场：2022 年和 2030 年趋势与市场占有率分析
  • 癌症
  • 多聚谷氨酰胺病
  • 自体免疫疾病
  • 思觉失调症
  • 其他的

第8章miRNA 定序与测定：最终用途估计与趋势分析

  • miRNA 定序与检测市场：重点
  • miRNA 定序与分析市场：2022 年和 2030 年趋势与市场占有率分析
  • 製药和生物技术产业
    • 2018年至2030年製药和生物技术产业的市场估计与预测
  • 研究和学术机构
    • 研究和学术机构2018年至2030年市场估计和预测
  • 其他的
    • 2018 年至 2030 年其他市场估计与预测

第9章miRNA 定序与检测：区域估计与趋势分析

  • 区域展望
  • 按地区分類的 miRNA 定序和检测市场：要点
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第10章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • Thermo Fisher Scientific, Inc.
    • Illumina, Inc.
    • QIAGEN
    • PerkinElmer, Inc
    • Abcam plc
    • New England Biolabs
    • Takara Bio Inc.
    • Lexogen GmbH
    • Norgen Biotek Corp.
    • Maravai LifeSciences
    • HTG Molecular Diagnostics, Inc.
    • Meridian Bioscience, Inc.
    • System Biosciences, LLC
Product Code: GVR-4-68039-394-2

miRNA Sequencing And Assay Market Growth & Trends:

The global miRNA sequencing and assay market size is expected to reach USD 823.5 Million by 2030, registering a CAGR of 13.3% from 2023 to 2030, according to a new report by Grand View Research, Inc.. For instance, various research studies stated that miRNAs can be efficiently used as biomarkers in the prognosis and diagnosis of cancer (cervical, ovarian, and breast), sepsis, cardiovascular diseases, and nervous system conditions. Thus, miRNA sequence analysis is significantly employed for gene regulation analysis in clinical disorders. For instance, an article published in frontiers, in March 2022, stated that blood-based miRNA biomarkers could be used to correlate brain-based miRNA expression.

The COVID-19 pandemic has enhanced the usage of miRNA to identify the presence of coronavirus. miRNA biomarkers have potential application to indicate and diagnose the COVID-19 severity. It plays a significant role in immune response, viral proliferation, replication of infected cells, and cardiovascular dysfunction. In addition, plasma recovered from COVID-19 patients is rich in antibodies and antiviral miRNAs. It has been utilized to treat COVID-19-infected patients. This has resulted in increasing research studies that focus on the miRNA sequence analysis from the patient as well as the virus.

Prominent players such as PerkinElmer Inc.; Illumina, Inc.; and Qiagen offer innovative sequencing products for several clinical applications. Furthermore, these companies have entered into several strategic initiatives with research institutes to expand the sequencing application in research studies. For instance, in January 2022, BIORCHESTRA, a South Korean biopharmaceutical company, entered into a partnership agreement with SK Biopharmaceuticals to accelerate research and development into novel therapeutic compounds that target miRNAs.

Key market players are involved in the development of new tools, instruments, and kits with high specificity and reproducibility, which is fueling the market growth. For instance, in October 2019, TriLink BioTechnologies introduced two primer sets for its CleanTag kit. Thermo Fisher Scientific's sequencer platform can prepare small RNA libraries using these new Ion Torrent Convert barcode primer sets. Such launches are expected to boost market growth.

miRNA Sequencing And Assay Market Report Highlights:

  • The products segment dominated the market with the largest revenue share of around 80% in 2022. This is due to the presence of several key companies that offer a broad range of consumables, kits, and instruments for specific applications
  • By technology, the sequencing by synthesis segment dominated the market with the largest revenue share of over 32% in 2022. This is due to its fast turnaround time, high sensitivity, and high throughput. Moreover, it plays a key role in the mutation detection of tumor tissue, which helps to develop personalized therapies
  • By workflow, the sequencing segment dominated the market with the largest revenue share of over 50% in 2022 and is expected to grow at the fastest CAGR of 14.1% over the forecast period as it is the most important step in the workflow. It has become a key research tool in biological research and several disease diagnoses
  • By application, the cancer segment dominated the market and accounted for the largest revenue share of over 35% in 2022. Several ongoing research in cancer using miRNA as a biomarker to study the prognosis and diagnosis of cancer to develop new therapies is contributing to the segment growth
  • By end-use, the research and academic institutes segment dominated the market and accounted for the largest revenue share of over 50% in 2022. The growth is attributed to the increased R&D studies conducted by academic institutes using miRNA sequencing techniques
  • Asia Pacific is expected to grow at the fastest CAGR of 15.4% during the forecast period. This is due to the growing healthcare infrastructure, significant targeted population, and high unmet clinical needs

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product & Service
    • 1.1.2. Technology
    • 1.1.3. Workflow
    • 1.1.4. Application
    • 1.1.5. End use
    • 1.1.6. Regional scope
    • 1.1.7. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product & service outlook
    • 2.2.2. Technology outlook
    • 2.2.3. Workflow outlook
    • 2.2.4. Application outlook
    • 2.2.5. End use outlook
    • 2.2.6. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. miRNA Sequencing And Assay Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. miRNA Sequencing And Assay Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. miRNA Sequencing And Assay: Product & Service Estimates & Trend Analysis

  • 4.1. miRNA Sequencing And Assay Market: Key Takeaways
  • 4.2. miRNA Sequencing And Assay Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Products
    • 4.3.1. Products market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.2. Library preparation kits
      • 4.3.2.1. Library preparation kits market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.3. Sequencing consumables
      • 4.3.3.1. Sequencing consumables market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.4. Instruments
      • 4.3.4.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Services
    • 4.4.1. Services market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. MiRNA Sequencing And Assay: Technology Estimates & Trend Analysis

  • 5.1. MiRNA Sequencing And Assay Market: Key Takeaways
  • 5.2. MiRNA Sequencing And Assay Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Sequencing by synthesis
    • 5.3.1. Sequencing by synthesis market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Sequencing By Oligonucleotide Ligation and Detection (SOLiD)
    • 5.4.1. Sequencing by oligonucleotide ligation and detection (SOLiD) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Nanopore Sequencing
    • 5.5.1. Nanopore sequencing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Sanger Sequencing
    • 5.6.1. Sanger sequencing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Single molecule real - time (SMRT) Sequencing
    • 5.7.1. Single molecule real - time (SMRT) sequencing market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. MiRNA Sequencing And Assay: Workflow Estimates & Trend Analysis

  • 6.1. MiRNA Sequencing And Assay Market: Key Takeaways
  • 6.2. MiRNA Sequencing And Assay Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Library Preparation
    • 6.3.1. Library preparation market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Sequencing
    • 6.4.1. Sequencing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Data analysis & storage
    • 6.5.1. Data analysis & storage market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. MiRNA Sequencing And Assay: Application Estimates & Trend Analysis

  • 7.1. MiRNA Sequencing And Assay Market: Key Takeaways
  • 7.2. MiRNA Sequencing And Assay Market: Movement & Market Share Analysis, 2022 & 2030
  • 7.3. Cancer
    • 7.3.1. Cancer market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4. Polyglutamine Diseases
    • 7.4.1. Polyglutamine diseases market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. Autoimmune Disease
    • 7.5.1. Autoimmune disease market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6. Schizophrenia
    • 7.6.1. Schizophrenia market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.7. Others
    • 7.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. MiRNA Sequencing And Assay: End Use Estimates & Trend Analysis

  • 8.1. MiRNA Sequencing And Assay Market: Key Takeaways
  • 8.2. MiRNA Sequencing And Assay Market: Movement & Market Share Analysis, 2022 & 2030
  • 8.3. Pharmaceutical & Biotechnology Industry
    • 8.3.1. Pharmaceutical & biotechnology industry market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.4. Research & Academic Institutes
    • 8.4.1. Research & academic institutes market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.5. Others
    • 8.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 9. MiRNA Sequencing And Assay: Regional Estimates & Trend Analysis

  • 9.1. Regional Outlook
  • 9.2. MiRNA Sequencing And Assay Market by Region: Key Takeaway
  • 9.3. North America
    • 9.3.1. North America market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
    • 9.3.2. U.S.
      • 9.3.2.1. U.S. market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
    • 9.3.3. Canada
      • 9.3.3.1. Canada market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
  • 9.4. Europe
    • 9.4.1. Europe market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
    • 9.4.2. UK
      • 9.4.2.1. UK market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
    • 9.4.3. Germany
      • 9.4.3.1. Germany market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
    • 9.4.4. France
      • 9.4.4.1. France market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
    • 9.4.5. Italy
      • 9.4.5.1. Italy market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
    • 9.4.6. Spain
      • 9.4.6.1. Spain market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
    • 9.4.7. Sweden
      • 9.4.7.1. Sweden market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
    • 9.4.8. Norway
      • 9.4.8.1. Norway market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
    • 9.4.9. Denmark
      • 9.4.9.1. Denmark market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
    • 9.5.2. Japan
      • 9.5.2.1. Japan market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
    • 9.5.3. China
      • 9.5.3.1. China market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
    • 9.5.4. India
      • 9.5.4.1. India market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
    • 9.5.5. Australia
      • 9.5.5.1. Australia market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
    • 9.5.6. Thailand
      • 9.5.6.1. Thailand market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
    • 9.5.7. South Korea
      • 9.5.7.1. South Korea market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
  • 9.6. Latin America
    • 9.6.1. Latin America market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
    • 9.6.2. Brazil
      • 9.6.2.1. Brazil market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
    • 9.6.3. Mexico
      • 9.6.3.1. Mexico market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
    • 9.6.4. Argentina
      • 9.6.4.1. Argentina market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
  • 9.7. MEA
    • 9.7.1. MEA market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
    • 9.7.2. Saudi Arabia
      • 9.7.2.1. Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
    • 9.7.3. South Africa
      • 9.7.3.1. South Africa market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
    • 9.7.4. UAE
      • 9.7.4.1. UAE market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
    • 9.7.5. Kuwait
      • 9.7.5.1. Kuwait market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 10.2. Market Participant Categorization
    • 10.2.1. Thermo Fisher Scientific, Inc.
      • 10.2.1.1. Company overview
      • 10.2.1.2. Financial performance
      • 10.2.1.3. Product benchmarking
      • 10.2.1.4. Strategic initiatives
    • 10.2.2. Illumina, Inc.
      • 10.2.2.1. Company overview
      • 10.2.2.2. Financial performance
      • 10.2.2.3. Product benchmarking
      • 10.2.2.4. Strategic initiatives
    • 10.2.3. QIAGEN
      • 10.2.3.1. Company overview
      • 10.2.3.2. Financial performance
      • 10.2.3.3. Product benchmarking
      • 10.2.3.4. Strategic initiatives
    • 10.2.4. PerkinElmer, Inc
      • 10.2.4.1. Company overview
      • 10.2.4.2. Financial performance
      • 10.2.4.3. Product benchmarking
      • 10.2.4.4. Strategic initiatives
    • 10.2.5. Abcam plc
      • 10.2.5.1. Company overview
      • 10.2.5.2. Financial performance
      • 10.2.5.3. Product benchmarking
      • 10.2.5.4. Strategic initiatives
    • 10.2.6. New England Biolabs
      • 10.2.6.1. Company overview
      • 10.2.6.2. Financial performance
      • 10.2.6.3. Product benchmarking
      • 10.2.6.4. Strategic initiatives
    • 10.2.7. Takara Bio Inc.
      • 10.2.7.1. Company overview
      • 10.2.7.2. Financial performance
      • 10.2.7.3. Product benchmarking
      • 10.2.7.4. Strategic initiatives
    • 10.2.8. Lexogen GmbH
      • 10.2.8.1. Company overview
      • 10.2.8.2. Financial performance
      • 10.2.8.3. Product benchmarking
      • 10.2.8.4. Strategic initiatives
    • 10.2.9. Norgen Biotek Corp.
      • 10.2.9.1. Company overview
      • 10.2.9.2. Financial performance
      • 10.2.9.3. Product benchmarking
      • 10.2.9.4. Strategic initiatives
    • 10.2.10. Maravai LifeSciences
      • 10.2.10.1. Company overview
      • 10.2.10.2. Financial performance
      • 10.2.10.3. Product benchmarking
      • 10.2.10.4. Strategic initiatives
    • 10.2.11. HTG Molecular Diagnostics, Inc.
      • 10.2.11.1. Company overview
      • 10.2.11.2. Financial performance
      • 10.2.11.3. Product benchmarking
      • 10.2.11.4. Strategic initiatives
    • 10.2.12. Meridian Bioscience, Inc.
      • 10.2.12.1. Company overview
      • 10.2.12.2. Financial performance
      • 10.2.12.3. Product benchmarking
      • 10.2.12.4. Strategic initiatives
    • 10.2.13. System Biosciences, LLC
      • 10.2.13.1. Company overview
      • 10.2.13.2. Financial performance
      • 10.2.13.3. Product benchmarking
      • 10.2.13.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
  • Table 3 North America miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
  • Table 4 North America miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
  • Table 5 North America miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
  • Table 6 North America miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
  • Table 7 North America miRNA sequencing and assay market, by region, 2018 - 2030 (USD Million)
  • Table 8 U.S. miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
  • Table 9 U.S. miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
  • Table 10 U.S. miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
  • Table 11 U.S. miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
  • Table 12 U.S. miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Canada miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
  • Table 14 Canada miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
  • Table 15 Canada miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
  • Table 16 Canada miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
  • Table 17 Canada miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
  • Table 18 Europe miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
  • Table 19 Europe miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
  • Table 20 Europe miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
  • Table 21 Europe miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
  • Table 22 Europe miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Europe miRNA sequencing and assay market, by region, 2018 - 2030 (USD Million)
  • Table 24 Germany miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
  • Table 25 Germany miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
  • Table 26 Germany miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
  • Table 27 Germany miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
  • Table 28 Germany miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
  • Table 29 UK miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
  • Table 30 UK miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
  • Table 31 UK miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
  • Table 32 UK miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
  • Table 33 UK miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
  • Table 34 France miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
  • Table 35 France miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
  • Table 36 France miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
  • Table 37 France miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
  • Table 38 France miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Italy miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
  • Table 40 Italy miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
  • Table 41 Italy miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
  • Table 42 Italy miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
  • Table 43 Italy miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Spain miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
  • Table 45 Spain miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
  • Table 46 Spain miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
  • Table 47 Spain miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
  • Table 48 Spain miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
  • Table 49 Sweden miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
  • Table 50 Sweden miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
  • Table 51 Sweden miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
  • Table 52 Sweden miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
  • Table 53 Sweden miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Norway miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
  • Table 55 Norway miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
  • Table 56 Norway miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
  • Table 57 Norway miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
  • Table 58 Norway miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
  • Table 59 Denmark miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
  • Table 60 Denmark miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
  • Table 61 Denmark miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
  • Table 62 Denmark miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
  • Table 63 Denmark miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
  • Table 67 Asia Pacific miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
  • Table 68 Asia Pacific miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Asia Pacific miRNA sequencing and assay market, by region, 2018 - 2030 (USD Million)
  • Table 70 China miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
  • Table 71 China miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
  • Table 72 China miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
  • Table 73 China miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
  • Table 74 China miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
  • Table 75 Japan miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
  • Table 76 Japan miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
  • Table 77 Japan miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
  • Table 78 Japan miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
  • Table 79 Japan miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
  • Table 80 India miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
  • Table 81 India miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
  • Table 82 India miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
  • Table 83 India miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
  • Table 84 India miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
  • Table 85 Australia miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
  • Table 86 Australia miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
  • Table 87 Australia miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
  • Table 88 Australia miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
  • Table 89 Australia miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
  • Table 90 Thailand miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
  • Table 91 Thailand miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
  • Table 92 Thailand miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
  • Table 93 Thailand miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
  • Table 94 Thailand miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
  • Table 95 South Korea miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
  • Table 96 South Korea miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
  • Table 97 South Korea miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
  • Table 98 South Korea miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
  • Table 99 South Korea miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
  • Table 100 Latin America miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
  • Table 101 Latin America miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
  • Table 102 Latin America miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
  • Table 103 Latin America miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
  • Table 104 Latin America miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
  • Table 105 Latin America miRNA sequencing and assay market, by region, 2018 - 2030 (USD Million)
  • Table 106 Brazil miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
  • Table 107 Brazil miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
  • Table 108 Brazil miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
  • Table 109 Brazil miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
  • Table 110 Brazil miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
  • Table 111 Mexico miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
  • Table 112 Mexico miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
  • Table 113 Mexico miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
  • Table 114 Mexico miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
  • Table 115 Mexico miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
  • Table 116 Argentina miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
  • Table 117 Argentina miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
  • Table 118 Argentina miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
  • Table 119 Argentina miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
  • Table 120 Argentina miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
  • Table 121 Middle East and Africa miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
  • Table 122 Middle East and Africa miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
  • Table 123 Middle East and Africa miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
  • Table 124 Middle East and Africa miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
  • Table 125 Middle East and Africa miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
  • Table 126 Middle East and Africa miRNA sequencing and assay market, by region, 2018 - 2030 (USD Million)
  • Table 127 South Africa miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
  • Table 128 South Africa miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
  • Table 129 South Africa miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
  • Table 130 South Africa miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
  • Table 131 South Africa miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
  • Table 132 Saudi Arabia miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
  • Table 133 Saudi Arabia miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
  • Table 134 Saudi Arabia miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
  • Table 135 Saudi Arabia miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
  • Table 136 Saudi Arabia miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
  • Table 137 UAE miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
  • Table 138 UAE miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
  • Table 139 UAE miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
  • Table 140 UAE miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
  • Table 141 UAE miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
  • Table 142 Kuwait miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
  • Table 143 Kuwait miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
  • Table 144 Kuwait miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
  • Table 145 Kuwait miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
  • Table 146 Kuwait miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 MiRNA sequencing and assay: Market outlook
  • Fig. 9 MiRNA sequencing and assay: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 MiRNA sequencing and assay market driver impact
  • Fig. 14 MiRNA sequencing and assay market restraint impact
  • Fig. 15 MiRNA sequencing and assay market strategic initiatives analysis
  • Fig. 16 MiRNA sequencing and assay market: Product & service movement analysis
  • Fig. 17 MiRNA sequencing and assay market: Product & service outlook and key takeaways
  • Fig. 18 Products market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Library preparation kits market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Sequencing consumables market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 MiRNA sequencing and assay market: Technology movement analysis
  • Fig. 24 MiRNA sequencing and assay market: Technology outlook and key takeaways
  • Fig. 25 Sequencing by synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Sequencing by oligonucleotide ligation and detection (solid) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Nanopore sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Sanger sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Single molecule real-time (SMRT) sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 MiRNA sequencing and assay market: Workflow movement analysis
  • Fig. 31 MiRNA sequencing and assay market: Workflow outlook and key takeaways
  • Fig. 32 Library preparation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Data analysis & storage market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 MiRNA sequencing and assay market: Application movement analysis
  • Fig. 36 MiRNA sequencing and assay market: Application outlook and key takeaways
  • Fig. 37 Cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Polyglutamine diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Autoimmune diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Schizophrenia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 MiRNA sequencing and assay market: End use movement analysis
  • Fig. 43 MiRNA sequencing and assay market: End use outlook and key takeaways
  • Fig. 44 Pharmaceutical & biotechnology industry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Research and academic institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Global MiRNA sequencing and assay market: Regional movement analysis
  • Fig. 48 Global MiRNA sequencing and assay market: Regional outlook and key takeaways
  • Fig. 49 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)